Chemical Component Summary

NameMasitinib
Identifiers4-[(4-methylpiperazin-1-yl)methyl]-~{N}-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide
FormulaC28 H30 N6 O S
Molecular Weight498.642
TypeNON-POLYMER
Isomeric SMILESCc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C
InChIInChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)
InChIKeyWJEOLQLKVOPQFV-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count66
Chiral Atom Count0
Bond Count70
Aromatic Bond Count23

Drug Info: DrugBank

DrugBank IDDB11526 
NameMasitinib
Groups
  • vet_approved
  • investigational
DescriptionMasitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in dogs. It has been available in Europe since 2009, under the brand name Masivet. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.
Synonyms
  • Masitinib
  • 4-((4-METHYLPIPERAZIN-1-YL)METHYL)-N-(4-METHYL-3-((4-PYRIDIN-3-YL-1,3-THIAZOL-2-YL)AMINO)PHENYL)BENZAMIDE
  • Masitinib mesylate
Categories
  • Acids, Carbocyclic
  • Amides
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Benzene Derivatives
ATC-CodeL01EX06
CAS number790299-79-5

Related Resource References

Resource NameReference
Pharos CHEMBL1908391
PubChem 10074640
ChEMBL CHEMBL1908391
ChEBI CHEBI:63450